Back

The impact of insurance status on the therapy and outcome of STEMI patients in Switzerland

29 August 2025 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Prognosis in acute coronary syndromes (1) Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mr Jan Loosli

UZH - Epidemiology, Biostatistics and Prevention Institute, Zurich (Switzerland)

6 More presentations in this session

Presentation thumbnail
Clinical characteristics and outcomes of NSTEMI patients with acute total occlusion
Doctor A. Low (Adelaide, AU)
Abstract Slides Video
Presentation thumbnail
Clinical characteristics and long-term prognosis of patients with premature acute myocardial infarction
Doctor S. Kim (Seongnam, KR)
Abstract Slides Video
Presentation thumbnail
Long-term outcomes in atrial fibrillation coronary embolism: a multicenter study
Mr A. Lanaspa Gallego (Pamplona, Navarra, ES)
Abstract Slides Video
Presentation thumbnail
The combined and mediating prognostic impact of inflammation and stress hyperglycemia in diabetic and nondiabetic patients with acute coronary syndrome
Doctor G. Zeng (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Prognostic significance of different body temperature trajectories and fever in patients with ST-segment elevation myocardial infarction
Doctor H. Zhang (Beijing, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Prognosis in acute coronary syndromes (1)

The Event

Event poster

ESC Congress 2025

29 August 2025 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Differences in treatment and outcome of patients with ST- Elevation Myocardial Infarction (STEMI) and Non-STEMI in Germany
thumbnail
Congress Presentation
Trends in early reperfusion therapy in non-ST-elevation myocardial infarction patients treated with PCI
thumbnail
Congress Presentation
Individual, socioeconomic and environmental predictors of STEMI mortality in Belgium: towards a holistic approach of the risk of cardiovascular death

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources